Showing results (131-140 of 174) with videos related to
Sort By:
Pageof 18
AIDS Research and Human Retroviruses|July 30, 2010
A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virusEftyhia Vardas, Pontiano Kaleebu, Linda-Gail Bekker, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 1, 2016
Assessment of Anti-HIV-1 Antibodies in Oral and Nasal Compartments of Volunteers From 3 Different PopulationsPhilip J Bergin, Robert Langat, Gloria Omosa-Manyonyi, et al.Plos One|February 19, 2013
Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteersSanjay Mehendale, Madhuri Thakar, Seema Sahay, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 30, 2013
Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1Nicola Borthwick, Tina Ahmed, Beatrice Ondondo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2021
A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral SyndromeAmin S Hassan, Jonathan Hare, Kamini Gounder, et al.Plos Pathogens|August 27, 2019
Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesisDaniel T Claiborne, Eileen P Scully, Christine D Palmer, et al.Plos One|April 16, 2015
Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trialPatricia J Munseri, Arne Kroidl, Charlotta Nilsson, et al.AIDS Research and Human Retroviruses|June 12, 2008
A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccineSanjay Mehendale, Jan van Lunzen, Nathan Clumeck, et al.Nature Communications|December 5, 2024
Dynamics of the blood plasma proteome during hyperacute HIV-1 infectionJamirah Nazziwa, Eva Freyhult, Mun-Gwan Hong, et al.Plos One|May 1, 2008
Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trialsWendy Stevens, Anatoli Kamali, Etienne Karita, et al.Pageof 18